Grey matter pathology in multiple sclerosis

被引:122
作者
Bö, L
Geurts, JJG
Mörk, SJ
van der Valk, P
机构
[1] VU Univ Med Ctr, MS Ctr, Dept Pathol, NL-1007 MB Amsterdam, Netherlands
[2] VU Univ Med Ctr, MS Ctr, Dept Radiol, NL-1007 MB Amsterdam, Netherlands
[3] Haukeland Univ Hosp, Dept Pathol, N-5021 Bergen, Norway
[4] Haukeland Univ Hosp, Dept Neurol, Natl Competence Ctr MS, N-5021 Bergen, Norway
[5] Univ Bergen, Gades Inst, Bergen, Norway
[6] Univ Bergen, Dept Clin Med, Bergen, Norway
来源
ACTA NEUROLOGICA SCANDINAVICA | 2006年 / 113卷
关键词
multiple sclerosis; demyelination; cerebral cortex; grey matter; axonal loss;
D O I
10.1111/j.1600-0404.2006.00615.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Although multiple sclerosis (MS) has been considered a white matter disease, MS lesions are known to occur in grey matter. Recent immunohistochemical studies have demonstrated extensive grey matter demyelination in chronic MS. The most common lesion type consists of purely cortical lesions extending inward from the surface of the brain, this lesion subgroup is grossly underestimated by standard histochemical myelin staining methods. Some MS patients have subpial demyelination in all cortical areas of the brain; this pattern has been termed ''general cortical subpial demyelination''. Extensive cortical demyelination is associated with the progressive phases of disease, as less cortical demyelination has been detected in relapsing-remitting MS. The pathology of grey matter lesions differs from that of white matter lesions; grey matter lesions are less inflammatory, with less macrophage and lymphocyte infiltration. In purely cortical lesions there is no significant increase in lymphocytes compared with non-demyelinated adjacent cortical areas in MS patients or cerebral cortex in control patients. Significant axonal transection and neuronal loss have been demonstrated in grey matter MS lesions. Current magnetic resonance imaging (MRI) methods are not sensitive for purely cortical MS lesions. The clinical significance of cortical MS lesions may not be characterised until more sensitive MRI methods are developed.
引用
收藏
页码:48 / 50
页数:3
相关论文
共 23 条
[11]  
Geurts JJG, 2005, AM J NEURORADIOL, V26, P572
[12]   Cortical lesions in multiple sclerosis [J].
Kidd, D ;
Barkhof, F ;
McConnell, R ;
Algra, PR ;
Allen, IV ;
Revesz, T .
BRAIN, 1999, 122 :17-26
[13]   Cortical demyelination and diffuse white matter injury in multiple sclerosis [J].
Kutzelnigg, A ;
Lucchinetti, CF ;
Stadelmann, C ;
Brück, W ;
Rauschka, H ;
Bergmann, M ;
Schmidbauer, M ;
Parisi, JE ;
Lassmann, H .
BRAIN, 2005, 128 :2705-2712
[14]   Neuropsychological impairment in multiple sclerosis patients: the role of (juxta)cortical lesion on FLAIR [J].
Lazeron, RHC ;
Langdon, DW ;
Filippi, M ;
van Waesberghe, JHTM ;
Stevenson, VL ;
Boringa, JBS ;
Origgi, D ;
Thompson, AJ ;
Falautano, M ;
Polman, C ;
Barkhof, F .
MULTIPLE SCLEROSIS JOURNAL, 2000, 6 (04) :280-285
[15]  
Moriarty DM, 1999, AM J NEURORADIOL, V20, P1956
[16]   HISTOPATHOLOGY OF MULTIPLE-SCLEROSIS LESIONS DETECTED BY MAGNETIC-RESONANCE-IMAGING IN UNFIXED POSTMORTEM CENTRAL-NERVOUS-SYSTEM TISSUE [J].
NEWCOMBE, J ;
HAWKINS, CP ;
HENDERSON, CL ;
PATEL, HA ;
WOODROOFE, MN ;
HAYES, GM ;
CUZNER, ML ;
MACMANUS, D ;
DUBOULAY, EPGH ;
MCDONALD, WI .
BRAIN, 1991, 114 :1013-1023
[17]   Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions [J].
Peterson, JW ;
Bö, L ;
Mörk, S ;
Chang, A ;
Trapp, BD .
ANNALS OF NEUROLOGY, 2001, 50 (03) :389-400
[18]  
Prineas J, 2002, GREENFIELDS NEUROPAT, P471
[19]  
Rovaris M, 2000, AM J NEURORADIOL, V21, P402
[20]  
Sander M., 1898, MONATSCHRIFT PSYCHIA, V4, P427